Sugemalimab Clinical Trials
3 recruitingDrug
Phase 22Phase 32Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC
NSCLC (Non-small Cell Lung Cancer)
Akeso560 enrolled1 locationNCT06617416
Recruiting
Phase 1Phase 2
Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
Lung CancerExtensive-stage Small-cell Lung Cancer
Sichuan University45 enrolled1 locationNCT06217757
Recruiting
Phase 2Phase 3
Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
Limited Stage Small Cell Lung Cancer
Sun Yat-sen University346 enrolled1 locationNCT05623267